Microbot Medical Inc. Segments Disclosure
NOTE 15 – SEGMENT REPORTING
Segment information is prepared on the same basis that the Company’s chief operating decision maker (“CODM”), the Chief Executive Officer, manages the business, makes business decisions and assesses performance. The Company has one operating and reportable segment, which is the development of robotic devices for endoluminal surgery. See Note 1A for further details.
The CODM assesses performance for this segment and decides how to allocate resources based on net loss. The measure of segment assets is reported on the balance sheet as cash and cash equivalents and marketable securities. The chief executive officer performs the assessment of segment performance by using the reported measure of segment loss to monitor actual results.
The table below summarizes the significant expense categories regularly reviewed by the CODM for the years ended December 31, 2025 and 2024:
| Year Ended December 31, | ||||||||
| 2025 | 2024 | |||||||
| Significant segment expenses | ||||||||
| Payroll and payroll related | $ | (7,435 | ) | $ | (5,376 | ) | ||
| Materials and subcontractors | (1,898 | ) | (2,165 | ) | ||||
| Share-based compensation | (1,057 | ) | (1,349 | ) | ||||
| Other segment items (*) | (2,752 | ) | (2,553 | ) | ||||
| Net loss | $ | (13,142 | ) | $ | (11,443 | ) | ||
| (*) | Other segment expense items included within net loss include professional services, patents, overhead and depreciation, travel expenses, financial income, net, other income and other miscellaneous expenses net of grants received. See the consolidated financial statements for other financial information regarding the Company’s operating segment. |
Long-lived assets and operating lease right-of-use assets by geographical areas were as follows:
| As of December 31, | ||||||||
| 2025 | 2024 | |||||||
| Israel | $ | 885 | $ | 209 | ||||
| United States | 41 | 3 | ||||||
| $ | 926 | $ | 212 | |||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 26, 2026 | Showing above |
| 2024 | Mar 25, 2025 | |
About Segments Disclosures
Segment disclosures break a company into its reportable operating units, revealing revenue, profit, and asset allocation that consolidated financial statements obscure. Under ASC 280, segments must match how the chief operating decision maker views the business, providing a window into internal management structure and resource allocation priorities.
Key signals: compare segment margins to identify which units drive profitability and which destroy value. Watch for changes in the number of reportable segments — segment aggregation or disaggregation often coincides with strategic shifts or attempts to obscure declining performance. Intersegment elimination patterns reveal internal pricing practices. The reconciliation between segment totals and consolidated figures exposes corporate overhead allocation and unallocated items. Geographic revenue concentration highlights regulatory and currency exposure. Compare segment-level capital expenditure against segment revenue to assess where management is investing for future growth versus harvesting existing assets.